This company listing is no longer active
2TG Stock Overview
Provides infection prevention products and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$173.42 |
| 52 Week High | US$232.90 |
| 52 Week Low | US$166.46 |
| Beta | 0.81 |
| 1 Month Change | 0% |
| 3 Month Change | 0.50% |
| 1 Year Change | -15.65% |
| 3 Year Change | 29.42% |
| 5 Year Change | n/a |
| Change since IPO | 542.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2TG | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | -0.6% |
| 1Y | -15.7% | -4.7% | 14.8% |
Return vs Industry: 2TG underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: 2TG underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 2TG volatility | |
|---|---|
| 2TG Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 2TG has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2TG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 16,000 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
| 2TG fundamental statistics | |
|---|---|
| Market cap | €17.98b |
| Earnings (TTM) | -€7.65m |
| Revenue (TTM) | €4.49b |
4.0x
P/S Ratio-2,352x
P/E RatioIs 2TG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2TG income statement (TTM) | |
|---|---|
| Revenue | US$4.78b |
| Cost of Revenue | US$2.70b |
| Gross Profit | US$2.08b |
| Other Expenses | US$2.09b |
| Earnings | -US$8.14m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.082 |
| Gross Margin | 43.49% |
| Net Profit Margin | -0.17% |
| Debt/Equity Ratio | 52.0% |
How did 2TG perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield-2,163%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/01/09 00:22 |
| End of Day Share Price | 2022/10/12 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
STERIS plc is covered by 25 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Michael Polark | Baird |
| Erin Wilson Wright | BofA Global Research |